[Evidence-based therapeutic guidelines for severe acute pancreatitis].
D000208:Acute Disease; D000900:Anti-Bacterial Agents; D003666:Decontamination; D004203:Disinfection / Q000379:methods; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D019317:Evidence-Based Medicine; D016670:Gabexate / Q000008:administration & dosage; D041981:Gastrointestinal Tract / Q000382:microbiology; D017583:Hemodiafiltration; D006801:Humans; D007262:Infusions, Intravenous; D010195:Pancreatitis / Q000628:therapy*; D010533:Peritoneal Lavage; D017410:Practice Guidelines as Topic; D011480:Protease Inhibitors / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index
D000900:Anti-Bacterial Agents; D011480:Protease Inhibitors; D016670:Gabexate